These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

602 related items for PubMed ID: 18956640

  • 1. [Effects of angiotensin II type 1 receptor blocker on triglyceride metabolism in the liver: experiment with Zucker fatty rats].
    Ran JM, Lao GC, Xu G, Xie B, Zhang Y, Liu W, Feng Q, Guo J.
    Zhonghua Yi Xue Za Zhi; 2008 Jun 10; 88(22):1557-61. PubMed ID: 18956640
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin II type 1 receptor blocker ameliorates overproduction and accumulation of triglyceride in the liver of Zucker fatty rats.
    Ran J, Hirano T, Adachi M.
    Am J Physiol Endocrinol Metab; 2004 Aug 10; 287(2):E227-32. PubMed ID: 15082419
    [Abstract] [Full Text] [Related]

  • 3. Olmesartan medoxomil, an angiotensin II receptor blocker ameliorates insulin resistance and decreases triglyceride production in fructose-fed rats.
    Okada K, Hirano T, Ran J, Adachi M.
    Hypertens Res; 2004 Apr 10; 27(4):293-9. PubMed ID: 15127887
    [Abstract] [Full Text] [Related]

  • 4. Chronic ANG II infusion increases plasma triglyceride level by stimulating hepatic triglyceride production in rats.
    Ran J, Hirano T, Adachi M.
    Am J Physiol Endocrinol Metab; 2004 Nov 10; 287(5):E955-61. PubMed ID: 15213064
    [Abstract] [Full Text] [Related]

  • 5. Calcium channel blocker azelnidipine reduces glucose intolerance in diabetic mice via different mechanism than angiotensin receptor blocker olmesartan.
    Iwai M, Li HS, Chen R, Shiuchi T, Wu L, Min LJ, Li JM, Tsuda M, Suzuki J, Tomono Y, Tomochika H, Mogi M, Horiuchi M.
    J Pharmacol Exp Ther; 2006 Dec 10; 319(3):1081-7. PubMed ID: 16990512
    [Abstract] [Full Text] [Related]

  • 6. [Effects of total glucosides of paeony on enhancing insulin sensitivity and antagonizing nonalcoholic fatty liver in rats].
    Zheng LY, Pan JQ, Lv JH.
    Zhongguo Zhong Yao Za Zhi; 2008 Oct 10; 33(20):2385-90. PubMed ID: 19157135
    [Abstract] [Full Text] [Related]

  • 7. Olmesartan ameliorates a dietary rat model of non-alcoholic steatohepatitis through its pleiotropic effects.
    Kurita S, Takamura T, Ota T, Matsuzawa-Nagata N, Kita Y, Uno M, Nabemoto S, Ishikura K, Misu H, Ando H, Zen Y, Nakanuma Y, Kaneko S.
    Eur J Pharmacol; 2008 Jul 07; 588(2-3):316-24. PubMed ID: 18501344
    [Abstract] [Full Text] [Related]

  • 8. Differences in plasma homocysteine levels between Zucker fatty and Zucker diabetic fatty rats following 3 weeks oral administration of organic vanadium compounds.
    Wasan KM, Risovic V, Yuen VG, McNeill JH.
    J Trace Elem Med Biol; 2006 Jul 07; 19(4):251-8. PubMed ID: 16443173
    [Abstract] [Full Text] [Related]

  • 9. Angiotensin II infusion decreases plasma adiponectin level via its type 1 receptor in rats: an implication for hypertension-related insulin resistance.
    Ran J, Hirano T, Fukui T, Saito K, Kageyama H, Okada K, Adachi M.
    Metabolism; 2006 Apr 07; 55(4):478-88. PubMed ID: 16546478
    [Abstract] [Full Text] [Related]

  • 10. Role of angiotensin II type-1 and type-2 receptors on vascular smooth muscle cell growth and glucose metabolism in diabetic rats.
    Igarashi M, Hirata A, Nozaki H, Kadomoto-Antsuki Y, Tominaga M.
    Diabetes Res Clin Pract; 2007 Mar 07; 75(3):267-77. PubMed ID: 16934905
    [Abstract] [Full Text] [Related]

  • 11. Vitamin A status affects obesity development and hepatic expression of key genes for fuel metabolism in Zucker fatty rats.
    Zhang Y, Li R, Li Y, Chen W, Zhao S, Chen G.
    Biochem Cell Biol; 2012 Aug 07; 90(4):548-57. PubMed ID: 22554462
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin II type 1 receptor antagonists prevent glucose-induced increases in islet blood flow in rats.
    Iwase M, Uchizono Y, Nohara S, Sasaki N, Sonoki K, Iida M.
    Scand J Clin Lab Invest; 2009 Aug 07; 69(1):145-50. PubMed ID: 18937099
    [Abstract] [Full Text] [Related]

  • 13. Preventive effects of a soy-based diet supplemented with stevioside on the development of the metabolic syndrome and type 2 diabetes in Zucker diabetic fatty rats.
    Dyrskog SE, Jeppesen PB, Colombo M, Abudula R, Hermansen K.
    Metabolism; 2005 Sep 07; 54(9):1181-8. PubMed ID: 16125530
    [Abstract] [Full Text] [Related]

  • 14. Angiotensin II infusion increases hepatic triglyceride production via its type 2 receptor in rats.
    Ran J, Hirano T, Adachi M.
    J Hypertens; 2005 Aug 07; 23(8):1525-30. PubMed ID: 16003179
    [Abstract] [Full Text] [Related]

  • 15. Effects of combined olmesartan and pravastatin on glucose intolerance and cardiovascular remodeling in a metabolic-syndrome model.
    Mizukawa M, Ohmori K, Obayashi A, Ishihara Y, Yoshida J, Noma T, Yukiiri K, Kosaka H, Kohno M.
    Hypertens Res; 2009 Jul 07; 32(7):617-24. PubMed ID: 19461650
    [Abstract] [Full Text] [Related]

  • 16. Conjugated docosahexaenoic acid inhibits lipid accumulation in rats.
    Tsuzuki T, Kawakami Y, Nakagawa K, Miyazawa T.
    J Nutr Biochem; 2006 Aug 07; 17(8):518-24. PubMed ID: 16426831
    [Abstract] [Full Text] [Related]

  • 17. Improvement of glucose intolerance by combination of pravastatin and olmesartan in type II diabetic KK-A(y) mice.
    Kanno H, Iwai M, Inaba S, Senba I, Nakaoka H, Sone H, Mogi M, Horiuchi M.
    Hypertens Res; 2009 Aug 07; 32(8):706-11. PubMed ID: 19478815
    [Abstract] [Full Text] [Related]

  • 18. Hyperlipidaemia is associated with increased insulin-mediated glucose metabolism, reduced fatty acid metabolism and normal blood pressure in transgenic mice overexpressing human apolipoprotein C1.
    Koopmans SJ, Jong MC, Que I, Dahlmans VE, Pijl H, Radder JK, Frölich M, Havekes LM.
    Diabetologia; 2001 Apr 07; 44(4):437-43. PubMed ID: 11357474
    [Abstract] [Full Text] [Related]

  • 19. Down-regulation of hepatic stearoyl-CoA desaturase 1 expression by angiotensin II receptor blocker in the obese fa/fa Zucker rat: possible role in amelioration of insulin resistance and hepatic steatosis.
    Yokozawa J, Sasaki T, Ohwada K, Sasaki Y, Ito JI, Saito T, Kawata S.
    J Gastroenterol; 2009 Apr 07; 44(6):583-91. PubMed ID: 19365601
    [Abstract] [Full Text] [Related]

  • 20. Angiotensin receptor-1 blocker inhibits atherosclerotic changes and endothelial disruption of the aortic valve in hypercholesterolemic rabbits.
    Arishiro K, Hoshiga M, Negoro N, Jin D, Takai S, Miyazaki M, Ishihara T, Hanafusa T.
    J Am Coll Cardiol; 2007 Apr 03; 49(13):1482-9. PubMed ID: 17397679
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.